↓ Skip to main content

Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis

Overview of attention for article published in BMC Pulmonary Medicine, September 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis
Published in
BMC Pulmonary Medicine, September 2012
DOI 10.1186/1471-2466-12-50
Pubmed ID
Authors

Fernando A L Marson, Carmen S Bertuzzo, Antônio F Ribeiro, José D Ribeiro

Abstract

The most common cystic fibrosis (CF) manifestation is the progressive chronic obstructive pulmonary disease caused by deficiency, dysfunction, or absence of the CFTR (Cystic Fibrosis Transmembrane Regulator) protein on the apical surface of the cells in the respiratory tract. The use of bronchodilators (BD), and inhaled corticosteroids (IC) have been suggested for the management of airway inflammation in CF. The effectiveness of BD and IC have been verified, proven in laboratory and in the clinical treatment for asthma patients. However, in CF, the effectiveness of these drugs is controversial. The extent of asthma's response to BD depends on the presence of polymorphisms in the ADRB2 gene. In contrast, in CF, little is known about the response to the BD and the association of CF´s severity with the different polymorphisms in ADRB2 gene. In this context, our objective was to verify whether the Arg16Gly and Glu27Gln polymorphisms in ADRB2 gene are associated with severity and with the bronchodilator response in CF patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 22%
Student > Bachelor 7 16%
Professor > Associate Professor 5 11%
Student > Postgraduate 4 9%
Researcher 4 9%
Other 11 24%
Unknown 4 9%
Readers by discipline Count As %
Medicine and Dentistry 17 38%
Agricultural and Biological Sciences 8 18%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Biochemistry, Genetics and Molecular Biology 3 7%
Nursing and Health Professions 3 7%
Other 4 9%
Unknown 6 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2019.
All research outputs
#17,665,425
of 22,678,224 outputs
Outputs from BMC Pulmonary Medicine
#1,249
of 1,893 outputs
Outputs of similar age
#124,306
of 169,211 outputs
Outputs of similar age from BMC Pulmonary Medicine
#17
of 25 outputs
Altmetric has tracked 22,678,224 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,893 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,211 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.